Detalles de la búsqueda
1.
Discovery and Model-Informed Drug Development of a Controlled-Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain.
Clin Pharmacol Ther
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822554
2.
Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.
Clin Pharmacol Ther
; 110(3): 808-815, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961287
Resultados
1 -
2
de 2
1
Próxima >
>>